Book a Discovery Call →
START-UP TOOLS

Tools we wish existed when we were scaling.

Each tool gives founders clarity, speed, and an unfair advantage in European markets. Some are live. Some are in build. All are designed to compress what would otherwise take months of consultant time into hours of decision-grade intelligence.

PRODUCT 01
Live

DeckScore - Free Evaluation

Know exactly where your pitch stands before you walk into the room.

Submit your investor or pitch deck and receive a structured assessment across 12 dimensions, scored against sector-specific benchmarks for BioTech, MedTech, HealthTech, and AI / Digital Health. Built on the same assessment methodology HealthSeed uses when evaluating companies for partnership.

12 DIMENSIONS
01
Problem & Market Opportunity
02
Clinical Evidence & Validation
03
Regulatory Pathway Clarity
04
Reimbursement & Market Access
05
Competitive Positioning
06
Business Model & Unit Economics
07
Team & Execution Capability
08
Technology & IP Defensibility
09
Go-to-Market Strategy
10
Financial Projections & Ask
11
Traction & Milestones
12
Risk Disclosure & Mitigation

Each dimension scored 1-5 with sector-specific weighting. A MedTech deck is evaluated differently from a HealthTech SaaS deck.

PAID ADVISORY SESSION

Paid Advisory Session

Walk through your DeckScore results with a senior HealthSeed partner and turn them into an action plan.

€400 · 45 minutes · paid in advance

Submit Your Deck (Free Analysis) →
PRODUCT 02
Free

Market Readiness Diagnostic

Five questions. One personalised intelligence snapshot.

Answer five questions about your product and target market. Receive a personalised readiness snapshot covering regulatory pathways, reimbursement feasibility, competitive density, and estimated timeline to first European revenue. Built on HealthSeed's proprietary intelligence covering 30+ EU markets.

HOW IT WORKS
01
Tell us about your product
Company, sector, product type, and current regulatory status.
02
Select your target market
Choose from 30+ European countries. We pull intelligence specific to your product category in that market.
03
Get your snapshot
Regulatory pathway complexity, reimbursement feasibility, competitive density, estimated timeline, and recommended entry approach.
WHAT THE SNAPSHOT COVERS
Regulatory pathway
MDR/IVDR classification indication and Notified Body landscape for your product type.
Reimbursement feasibility
High-level assessment of G-BA, HAS, NICE, or relevant national pathway for your product category.
Competitive density
How many similar products are already in market in your target country.
Timeline estimate
Indicative months from current status to first commercial revenue.
Recommended approach
Whether you're a fit for Launchpad, Focused GTM, or Assessment, and which specific modules apply.
Run Your Diagnostic →
PRODUCT 03
LiveFree

RegReady

Where your medical device sits under EU MDR and US FDA classification rules.

Your device class sets your route to market and your evidence burden long before you reach a Notified Body. RegReady shows you where your product sits under EU MDR and US FDA rules, across every class it could plausibly fall into, so you make that call deliberately rather than discover it late.

Free to use. The full classification assessment, with the detailed analysis and Notified Body strategy, is a separate paid engagement.

Built for medical device and diagnostic-software companies assessing EU and US entry. If your product is a therapeutic, a service, or not a regulated device, the Diagnostic is the better place to start.

WHAT YOU GET
MDR classification
Where your device sits under EU MDR Annex VIII, across Class I, IIa, IIb, and III, with the specific rule that drives it and the likelihood a Notified Body agrees.
FDA classification
The parallel US picture: your likely FDA class and pathway across 510(k), De Novo, and PMA, plus whether to sequence Europe or the US first.
What it means
What each classification changes commercially, from the evidence you must generate through to how investors read your file. Classification is a business decision, and this shows you the consequence of each route.

RegReady runs on the same regulatory classification engine HealthSeed uses in live MDR and IVDR client work.

PRODUCT 04
Coming 2027

GrantScale

Find the right EU grants. Win them. Manage them.

An AI-powered platform that matches your company to relevant European grants, helps you write competitive applications, and tracks your portfolio from submission through post-award reporting. Built on a continuously updated database covering Horizon Europe, EIC Accelerator, national programmes, and regional funding across 30+ EU markets.

THREE CAPABILITIES
01
Intelligent matching
Grant opportunities filtered by your sector, stage, geography, and eligibility. Not a keyword search. A relevance engine that understands your product and finds the programmes built for it.
02
AI-assisted writing
Structured application support calibrated to each programme's evaluation criteria. Section-by-section guidance, scoring predictions, and competitive positioning within the call.
03
Portfolio management
Deadline tracking, milestone reporting, and post-award compliance. One dashboard for every active and pending application.
PRODUCT 05
Live

2026/27 European Healthcare & Health Innovation Events Calendar

The conferences, summits and partnering events that matter across Europe.

A curated calendar of European healthcare conferences and events spanning AI in Healthcare, Biotech, MedTech, HealthTech, Digital Health and Life Sciences.

Find the regulatory, investor, clinical and commercial events where founders, investors and industry leaders meet to build partnerships, share market intelligence and advance healthcare innovation across European markets. Updated quarterly.

BEYOND THE TOOLS

Need something we have not built yet?

These tools are designed to give you a head start. For the full picture, tailored to your product and target markets, book a discovery call.

Book a Discovery Call →Explore our services →